Recommendations for research
The guideline committee has made the following key recommendations for research.
1 Simplifying risk assessment
What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD? [2014]
2 Statin treatment for older people
What is the effectiveness of statin treatment in older people? [May 2023, amended December 2023]
Why the committee made the recommendation for research
The committee agreed to retain the following recommendations for research because there is still a lack of direct evidence in these areas:
-
statin treatment for older people
-
lipid-lowering treatment for people with type 1 diabetes.
Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and adverse effects.
3 Lipid-lowering treatment for people with type 1 diabetes
What is the effectiveness of statins and/or other lipid-lowering treatment in people with type 1 diabetes? [May 2023, amended December 2023]
Why the committee made the recommendation for research
The committee agreed to retain the following recommendations for research because there is still a lack of direct evidence in these areas:
-
statin treatment for older people
-
lipid-lowering treatment for people with type 1 diabetes.
Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and adverse effects.